{"text_format":"2","workbook":"xlsx","n_sheets":1,"sheets":["Tabelle1"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":0,"defined_names":0,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"Tabelle1","index":0,"n_rows":71,"n_cols":7,"rows_kept":71,"cut":false,"hidden":false,"merged":[]}
["Supplementary Table 4: Over- and Underrepresentation of KEGG pathways in complex members that are targeted by miRNAs"]
[]
["Overrepresented"]
[]
["KEGGID","Pvalue","OddsRatio","ExpCount","Count","Size","Term"]
[5200,1.15909064702588E-014,3.64478792762435,48.1503105590062,93,166,"Pathways in cancer"]
[4510,1.16268638730244E-012,4.21040422200313,31.6167701863354,66,109,"Focal adhesion"]
[4810,1.11794832692427E-009,3.82673978326152,26.1055900621118,53,90,"Regulation of actin cytoskeleton"]
[5220,1.28287970919779E-009,6.09259259259259,14.5031055900621,35,50,"Chronic myeloid leukemia"]
[4310,2.72035145432765E-009,5.53241435785451,15.3732919254658,36,53,"Wnt signaling pathway"]
[5214,3.84817350611132E-009,7.50159817351598,11.3124223602484,29,39,"Glioma"]
[4520,3.88327188384777E-009,7.06469731641356,11.8925465838509,30,41,"Adherens junction"]
[5215,4.4643466115873E-008,5.1816091954023,13.9229813664596,32,48,"Prostate cancer"]
[4350,7.14937805143335E-008,6.67981859410431,10.4422360248447,26,36,"TGF-beta signaling pathway"]
[5212,9.41668846604405E-008,4.87248140635565,14.2130434782609,32,49,"Pancreatic cancer"]
[5218,4.97678169586018E-007,7.64125560538117,8.12173913043478,21,28,"Melanoma"]
[5100,7.91587407894996E-007,4.94853896103896,11.8925465838509,27,41,"Bacterial invasion of epithelial cells"]
[5211,8.95468286201642E-007,5.12471655328798,11.3124223602484,26,39,"Renal cell carcinoma"]
[5223,1.27330608588741E-006,6.22921348314607,8.99192546583851,22,31,"Non-small cell lung cancer"]
[5414,1.6220270262643E-006,4.61454545454545,12.1826086956522,27,42,"Dilated cardiomyopathy"]
[4910,1.9490195934026E-006,3.70266479663394,16.2434782608696,33,56,"Insulin signaling pathway"]
[4720,2.42456507407324E-006,5.10609480812641,10.4422360248447,24,36,"Long-term potentiation"]
[4330,3.5113007286201E-006,6.88265306122449,7.5416149068323,19,26,"Notch signaling pathway"]
[5412,7.1978358924582E-006,4.15277777777778,12.1826086956522,26,42,"Arrhythmogenic right ventricular cardiomyopathy (ARVC)"]
[4530,7.6983762277914E-006,3.24557351809084,17.6937888198758,34,61,"Tight junction"]
[4320,1.37550864053539E-005,"Inf",2.61055900621118,9,9,"Dorso-ventral axis formation"]
[4012,1.60564341089436E-005,3.58132118451025,13.9229813664596,28,48,"ErbB signaling pathway"]
[5410,4.21802226054606E-005,3.8954954954955,11.0223602484472,23,38,"Hypertrophic cardiomyopathy (HCM)"]
[5219,5.89000366343146E-005,5.75736458663288,6.67142857142857,16,23,"Bladder cancer"]
[4912,0.000105701764949372,3.38600451467269,12.1826086956522,24,42,"GnRH signaling pathway"]
[4114,0.000141028752265041,2.73125593166719,17.4037267080745,31,60,"Oocyte meiosis"]
[4130,0.000145635250336567,5.38558786346397,6.38136645962733,15,22,"SNARE interactions in vesicular transport"]
[4010,0.000169765599475384,2.2272284800445,27.555900621118,44,95,"MAPK signaling pathway"]
[5222,0.000176676292126994,2.73373651520105,16.8236024844721,30,58,"Small cell lung cancer"]
[4722,0.000178955348986731,2.49131944444444,20.5944099378882,35,71,"Neurotrophin signaling pathway"]
[5210,0.000216841056200897,3.23761261261261,11.8925465838509,23,41,"Colorectal cancer"]
[5213,0.000350665711376449,3.77839643652561,8.70186335403727,18,30,"Endometrial cancer"]
[4916,0.000500834952140106,3.42012117346939,9.57204968944099,19,33,"Melanogenesis"]
[5221,0.000500834952140106,3.42012117346939,9.57204968944099,19,33,"Acute myeloid leukemia"]
[4512,0.000813205675335224,2.63716063348416,14.2130434782609,25,49,"ECM-receptor interaction"]
[4370,0.00157719756226306,3.34368070953437,8.12173913043478,16,28,"VEGF signaling pathway"]
[4020,0.00214858722501493,2.4227539503386,14.2130434782609,24,49,"Calcium signaling pathway"]
[4660,0.00215104573084405,2.27659090909091,16.5335403726708,27,57,"T cell receptor signaling pathway"]
[4972,0.00228303593278076,4.57127192982456,4.93105590062112,11,17,"Pancreatic secretion"]
[4971,0.00239127589258591,3.50154525386313,6.96149068322981,14,24,"Gastric acid secretion"]
[4662,0.0029474153836661,2.51569506726457,12.1826086956522,21,42,"B cell receptor signaling pathway"]
[4144,0.00328404135516796,1.87400811144419,26.6857142857143,39,92,"Endocytosis"]
[5131,0.00369834829840362,2.51230425055928,11.6024844720497,20,40,"Shigellosis"]
[4730,0.0039591331111203,2.65531245905935,10.1521739130435,18,35,"Long-term depression"]
[4110,0.00527997294889351,1.78478984346111,28.1360248447205,40,97,"Cell cycle"]
[4062,0.00624264368276122,1.94331983805668,20.0142857142857,30,69,"Chemokine signaling pathway"]
[4360,0.00643073653733951,2.91280353200883,7.5416149068323,14,26,"Axon guidance"]
[5217,0.00739171798805254,4.96296296296296,3.48074534161491,8,12,"Basal cell carcinoma"]
[5142,0.00865968505387736,1.98309626881055,17.1136645962733,26,59,"Chagas disease (American trypanosomiasis)"]
[]
[]
["Underrepresented"]
[]
["KEGGID","Pvalue","OddsRatio","ExpCount","Count","Size","Term"]
[3010,4.19887792800053E-011,0,19.7242236024845,0,68,"Ribosome"]
[190,2.53911763753012E-010,0,18.2739130434783,0,63,"Oxidative phosphorylation"]
[1100,3.15297235566021E-009,0.245721629359708,43.7993788819876,15,151,"Metabolic pathways"]
[5012,1.07833370787991E-008,0.0934005125815471,22.3347826086957,3,77,"Parkinson's disease"]
[3050,7.5615391658709E-006,0,9.86211180124224,0,34,"Proteasome"]
[3013,0.000189832368603224,0.325492341356674,23.7850931677019,10,82,"RNA transport"]
[230,0.000354808460169834,0.13615975422427,10.732298136646,2,37,"Purine metabolism"]
[5010,0.000481194048227205,0.385657725980037,26.6857142857143,13,92,"Alzheimer's disease"]
[240,0.000787605652980281,0.0886981402002861,8.12173913043478,1,28,"Pyrimidine metabolism"]
[3020,0.00571016531782898,0,4.35093167701863,0,15,"RNA polymerase"]
[5340,0.0069260231067503,0.12049356223176,6.09130434782609,1,21,"Primary immunodeficiency"]
[5016,0.00704030854733919,0.536404311572097,31.3267080745342,20,108,"Huntington's disease"]